N-(3-(2-(4-chlorophenoxy)acetamido)bicyclo[1.1.1] pentan-1-yl)-2-cyclobutane-1- carboxamide derivatives and related compounds as atf4 inhibitors for treating cancer and other diseases
AssigneeGlaxoSmithKline Intellectual Property Development Limited
InventorsMui CHEUNG, Michael P. DEMARTINO, Biswajit KALITA
Life of this patent
Estimating the term…